You are here

Home

Vaccinations

EU clears Moderna shot for young children, Pfizer boosters

Thu, 2022-03-03 10:24 — mike kraft
EU clears Moderna shot for young kids, Pfizer boosters AMSTERDAM (AP) — The European Medicines Agency said it has authorized Moderna's coronavirus vaccine for children aged six to 11, in addition to recommending booster shots of Pfizer's vaccine for those aged 12 and over, in decisions aimed at providing further protection against COVID-19 for children across Europe. AP NEWS

...

Country / Region Tags: 
Europe
Global
United States
General Topic Tags: 
COVID-19
Contagion
Demographics
Disease
Disease Prevention
Government
Health
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

India's output, exports of Russia's Sputnik vaccine may be at risk due to Ukraine crisis --Russian fund source

Wed, 2022-03-02 12:27 — mike kraft
India's output, exports of Russia's Sputnik vaccine at risk due to Ukraine crisis India's production and exports of Russia's Sputnik COVID-19 vaccines are expected to slow further following U.S. sanctions on Russia's sovereign wealth fund that promotes the shot globally, three Indian pharmaceutical industry sources told Reuters. Krishna N. Das Reuters
Country / Region Tags: 
Global
India
Russia
SouthEast Asia
General Topic Tags: 
COVID-19
Disease Prevention
Government
Health
Pandemics
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Inovio lab tests show COVID vaccine weaker against Omicron, study focus to change

Wed, 2022-03-02 10:28 — mike kraft
Inovio lab tests show COVID vaccine weaker against Omicron, trial enrollment paused Inovio Pharmaceuticals Inc has paused enrollment for an ongoing late-stage study of its lead COVID-19 vaccine candidate after the shot showed significantly lower levels of antibodies against the Omicron variant in lab testing. Reuters Reuters

 

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Disease Prevention
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Pfizer shots protect kids from severe COVID even in omicron --new data

Tue, 2022-03-01 17:35 — mike kraft
Pfizer shots protect kids from severe COVID even in omicron Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge that hit youngsters especially hard, U.S. health officials reported Tuesday. AP NEWS

...

Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
COVID-19
Data
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

From Alabama to Utah, Efforts to Vaccinate Medicaid Enrollees Against Covid Run Into Obstacles

Tue, 2022-03-01 11:53 — mike kraft
From Alabama to Utah, Efforts to Vaccinate Medicaid Enrollees Against Covid Run Into Obstacles Inoculation rates remain low despite massive outreach efforts and incentives from federal and state programs and Medicaid plan operators, leaving many low-income people vulnerable to the virus. khnphilipg Kaiser Health News

Medicaid enrollees continue to get vaccinated against covid at far lower rates than the general population despite vigorous outreach efforts by government officials and private organizations to get low-income people inoculated, according to data from several states.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Contagion
Data
Demographics
Disease
Disease Prevention
Government
Health
Pandemics
Public Attitudes
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Ovedrview: Hong Kong, various vaccine-related developments

Tue, 2022-03-01 10:30 — mike kraft
What you need to know about the coronavirus right now Here's what you need to know about the coronavirus right now: Reuters Reuters
Country / Region Tags: 
China
Europe
SouthEast Asia
United States
General Topic Tags: 
COVID-19
Disease
Health
Pandemics
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

EU drug regulator extends shelf life of J&J vaccine to 11 months

Mon, 2022-02-28 18:42 — mike kraft
EU drug regulator extends shelf life of J&J vaccine to 11 months The European drug regulator extended the shelf life of Johnson & Johnson's COVID-19 vaccine to 11 months from 4.5 months, updated product information showed on Monday. Reuters Reuters
Country / Region Tags: 
Europe
United States
General Topic Tags: 
COVID-19
Disease Prevention
Government
Health
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Analysis: Is WHO's aim to vaccinate 70% of world by June still realistic?

Mon, 2022-02-28 09:47 — mike kraft
Analysis: Is WHO's aim to vaccinate 70% of world by June still realistic? Vaccinating 70% of the population in every country in the world against COVID-19 by mid-2022 has been the World Health Organization's (WHO) rallying cry to end the pandemic. Jennifer Rigby Reuters
Country / Region Tags: 
Africa
Democratic Republic of the Congo
Ghana
Global
Haiti
Nigeria
Sierra Leone
SouthEast Asia
United Nations
General Topic Tags: 
COVID-19
Contagion
Demographics
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Policy
Public Health
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Overview: Asia developments, Hong Kong, South Korea, China vaccine situation

Mon, 2022-02-28 09:30 — mike kraft

Feb 28 (Reuters) --  ...

Hong Kong mortuaries hit capacity

 -- Facilities for storing dead bodies at hospitals and public mortuaries in Hong Kong are at maximum capacity due to a record number of COVID-19 fatalities, the Hospital Authority said on Monday, as officials battle to control a surge in cases.

Country / Region Tags: 
China
Global
South Korea
General Topic Tags: 
COVID-19
Contagion
Data
Disease
Government
Health
Pandemics
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

CDC STAFF explains Why Lengthen mRNA Vaccine Dosing Interval

Fri, 2022-02-25 11:43 — mike kraft
Why Lengthen mRNA Vaccine Dosing Interval? CDC Staff Explain International data indicated lower risks, higher benefits for certain younger populations Molly Walker medpagetoday

Extended dosing intervals for Pfizer or Moderna vaccines may be considered for certain individuals ages 12 to 64 years, not only to lower the risk of vaccine-associated myocarditis, but to potentially improve vaccine effectiveness, CDC staff said on Thursday.

According to the agency's new interim guidance, young people ages 12 to 39 may especially benefit from a second mRNA dose 8 weeks after their first dose.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Pages

Subscribe to Vaccinations
howdy folks
Page loaded in 0.842 seconds.